Standout Papers

MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia 2006 2026 2012 2019 1.0k
  1. MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia (2006)
    Yana Pikman, Benjamin H. Lee et al. PLoS Medicine

Immediate Impact

2 by Nobel laureates 30 from Science/Nature 59 standout
Sub-graph 1 of 19

Citing Papers

JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Depleting myeloid-biased haematopoietic stem cells rejuvenates aged immunity
2024 StandoutNature
3 intermediate papers

Works of Sandra Moore being referenced

Efficacy of TG101348, a Selective JAK2 Inhibitor, in Treatment of a Murine Model of JAK2V617F-Induced Polycythemia Vera
2008
MPLW515L Is a Novel Somatic Activating Mutation in Myelofibrosis with Myeloid Metaplasia
2006 Standout

Author Peers

Author Last Decade Papers Cites
Sandra Moore 957 1264 1073 11 1.7k
Rachel Okabe 1200 998 1030 22 2.0k
Ping Chen 532 735 1143 23 1.6k
George F. Barker 709 463 915 7 1.6k
Maricel Gozo 1274 1260 1103 21 2.1k
Linda Richmond 313 737 1074 15 1.3k
G Grosveld 436 744 1116 13 1.5k
Hui Hao-Shen 956 1316 1216 34 1.8k
Guillermo Garcia‐Manero 526 819 1301 34 1.7k
JL Laï 539 1074 1172 17 1.5k
Niove E. Jordanides 290 629 855 13 1.2k

All Works

Loading papers...

Rankless by CCL
2026